BXRXQ — Baudax Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $13.91m
- $1.27m
Baudax Bio Inc expected to post a loss of $2.35 a share - Earnings Preview
Baudax Bio Inc expected to post a loss of $2.35 a share - Earnings Preview
Brief: Baudax Bio Says Chairman Alfred Altomari Notified Of His Intent To Resign From Board Immediately Following 2022 Annual Meeting
Baudax Bio Inc reports results for the quarter ended in December - Earnings Summary
Brief: Baudax Bio Reports Net Income Of $10.03 Per Diluted Share
Baudax Bio Inc expected to post earnings of $1.48 a share - Earnings Preview
Brief: Baudax Bio Initiates Phase IV Clinical Trial Evaluating Anjeso In Pediatric Patients Following Surgery
Brief: Baudax Bio Regains Compliance With Nasdaq Listing Requirements
Baudax Bio Inc expected to post a loss of 77 cents a share - Earnings Preview
Baudax Bio Inc expected to post a loss of 77 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baudax Bio, Farfetch, Foot Locker
U.S. STOCKS ON THE MOVE-Baudax Bio, Farfetch Ltd, Foot Locker
U.S. STOCKS ON THE MOVE-Zscaler Inc, Foot Locker
Baudax Bio plunges on $10 mln stock-and-warrants offering
Brief: Baudax Bio Says Announced Pricing Of Its Previously Announced Underwritten Public Offering Of 3.5 Million Shares Of Common Stock
Brief: Baudax Bio Announces Proposed Public Offering Of Securities
Baudax Bio Inc expected to post a loss of 77 cents a share - Earnings Preview
Brief: Baudax Bio Announces 1-For-35 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Tencent Music, Baudax Bio, Novavax